206 related articles for article (PubMed ID: 33497035)
1. Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis.
Russo B; Borowczyk J; Boehncke WH; Truchetet ME; Modarressi A; Brembilla NC; Chizzolini C
Arthritis Rheumatol; 2021 Jul; 73(7):1311-1317. PubMed ID: 33497035
[TBL] [Abstract][Full Text] [Related]
2. IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.
Russo B; Borowczyk J; Cacialli P; Moguelet P; Truchetet ME; Modarressi A; Brembilla NC; Bertrand J; Boehncke WH; Chizzolini C
Rheumatology (Oxford); 2022 Nov; 61(11):4558-4569. PubMed ID: 35171244
[TBL] [Abstract][Full Text] [Related]
3. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
[TBL] [Abstract][Full Text] [Related]
4. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
5. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.
Brembilla NC; Dufour AM; Alvarez M; Hugues S; Montanari E; Truchetet ME; Lonati P; Fontao L; Gabrielli A; Vettori S; Valentini G; Boehncke WH; Meroni P; Chizzolini C
Ann Rheum Dis; 2016 Sep; 75(9):1697-705. PubMed ID: 26452537
[TBL] [Abstract][Full Text] [Related]
6. Contribution of keratinocytes to dermal fibrosis.
Russo B; Brembilla NC; Chizzolini C
Curr Opin Rheumatol; 2022 Nov; 34(6):337-342. PubMed ID: 35994728
[TBL] [Abstract][Full Text] [Related]
7. Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.
Nikitorowicz-Buniak J; Shiwen X; Denton CP; Abraham D; Stratton R
J Invest Dermatol; 2014 Nov; 134(11):2693-2702. PubMed ID: 24933320
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
9. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
[TBL] [Abstract][Full Text] [Related]
10. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
11. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells.
Mastrofrancesco A; Alfè M; Rosato E; Gargiulo V; Beatrice C; Di Blasio G; Zhang B; Su DS; Picardo M; Fiorito S
J Immunol Res; 2014; 2014():138751. PubMed ID: 24982919
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
[TBL] [Abstract][Full Text] [Related]
14. CXCL17-mediated downregulation of type I collagen via MMP1 and miR-29 in skin fibroblasts possibly contributes to the fibrosis in systemic sclerosis.
Shimada S; Makino K; Jinnin M; Sawamura S; Kawano Y; Ide M; Kajihara I; Makino T; Fukushima S; Ihn H
J Dermatol Sci; 2020 Dec; 100(3):183-191. PubMed ID: 33055012
[TBL] [Abstract][Full Text] [Related]
15. Irinotecan and its metabolite SN38 inhibits procollagen I production of dermal fibroblasts from Systemic Sclerosis patients.
Lapoirie J; Tran L; Piazza L; Contin-Bordes C; Truchetet ME; Bonnet F
Sci Rep; 2021 Sep; 11(1):18011. PubMed ID: 34504265
[TBL] [Abstract][Full Text] [Related]
16. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
17. Chronic exposure of interleukin-13 suppress the induction of matrix metalloproteinase-1 by tumour necrosis factor α in normal and scleroderma dermal fibroblasts through protein kinase B/Akt.
Brown Lobbins ML; Shivakumar BR; Postlethwaite AE; Hasty KA
Clin Exp Immunol; 2018 Jan; 191(1):84-95. PubMed ID: 28884475
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.
Arvia R; Margheri F; Stincarelli MA; Laurenzana A; Fibbi G; Gallinella G; Ferri C; Del Rosso M; Zakrzewska K
Rheumatology (Oxford); 2020 Nov; 59(11):3526-3532. PubMed ID: 32556240
[TBL] [Abstract][Full Text] [Related]
19. High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.
Lonati PA; Brembilla NC; Montanari E; Fontao L; Gabrielli A; Vettori S; Valentini G; Laffitte E; Kaya G; Meroni PL; Chizzolini C
PLoS One; 2014; 9(8):e105008. PubMed ID: 25136988
[TBL] [Abstract][Full Text] [Related]
20. IL-1 receptor antagonist attenuates MAP kinase/AP-1 activation and MMP1 expression in UVA-irradiated human fibroblasts induced by culture medium from UVB-irradiated human skin keratinocytes.
Wang X; Bi Z; Chu W; Wan Y
Int J Mol Med; 2005 Dec; 16(6):1117-24. PubMed ID: 16273295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]